Doug Besch - Feb 15, 2024 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role: Chief Product Officer
Signature: /s/ Marion Odence-Ford, by Power of Attorney
Stock symbol: OPRX
Transactions as of: Feb 15, 2024
Transactions value $: $0
Form type: 4
Date filed: 4/24/2024, 10:18 AM
Previous filing: Feb 21, 2024
Next filing: Oct 7, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OPRX	Common Stock	Award	$0	+4K	+103.95%	$0.00	7.85K	Feb 15, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on February 15, 2025, which is the first anniversary of the date of grant.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.